Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty
about
Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cellsPost-translational modification of the myxoma-virus anti-inflammatory serpin SERP-1 by a virally encoded sialyltransferaseApplication of linear free energy relationships to the serpin-proteinase inhibition mechanismDetection of transplant vasculopathy in a rat aortic allograft model by fluorescence spectroscopic optical analysisInhibitory specificity of the anti-inflammatory myxoma virus serpin, SERP-1Identification of myxomaviral serpin reactive site loop sequences that regulate innate immune responsesAnti-inflammatory therapies for cardiovascular diseaseSerp-1, a viral anti-inflammatory serpin, regulates cellular serine proteinase and serpin responses to vascular injury.Myxomavirus anti-inflammatory chemokine binding protein reduces the increased plaque growth induced by chronic Porphyromonas gingivalis oral infection after balloon angioplasty aortic injury in mice.Viral antichemokines: from pathogenesis to drug discovery.Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro.Virokines: novel immunomodulatory agents.Polymicrobial infection with major periodontal pathogens induced periodontal disease and aortic atherosclerosis in hyperlipidemic ApoE(null) mice.Poxvirus immunomodulatory strategies: current perspectivesTechnical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes.Chronic oral infection with major periodontal bacteria Tannerella forsythia modulates systemic atherosclerosis risk factors and inflammatory markers.Protein therapeutics--lessons learned and a view of the future.Suppression of neointimal hyperplasia following angioplasty-induced vascular injury in pigs infected with swinepox virusExpression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.Reactive Center Loop (RCL) Peptides Derived from Serpins Display Independent Coagulation and Immune Modulating ActivitiesMyxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection.Viral serpin therapeutics from concept to clinic.Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release.Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury.Increased atherogenesis during Streptococcus mutans infection in ApoE-null miceHarvesting viral proteins.Viral-derived Serp-1 as an adjunctive therapy for percutaneous coronary intervention: another not ready for prime time player?In vivo optical analysis of quantitative changes in collagen and elastin during arterial remodeling.Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B.Immunopathogenesis of infectious disease: injury and death from friendly fire.Emerging evidence for inflammation in conditions frequently affecting older adults: report of a symposium.
P2860
Q24527273-72D7B64A-2DFE-4591-811F-3BEC2B5A93D7Q24532008-08558632-62E9-4D24-9243-E3BCA8B7F883Q28138385-27E39C2D-F710-4E89-B137-39BB12448136Q28139659-0FB8F355-7806-4129-B675-A824DD9C4C47Q28278811-2BC6AF93-207F-457B-A892-E3FE3BCCEC39Q28291150-73567984-FAEC-487E-8167-91818DEC4C19Q34137872-ACA33C9D-247A-44CE-B001-F680D92B2DDCQ34183636-172D00D1-BAFE-4113-85B1-9104DECDCBBCQ34420992-9CB7599E-0738-49ED-B1BE-B5C2E55EB352Q34433825-BEE3B1A5-D1F1-4B81-8BAC-6676C68AD8E1Q34437925-2A77C039-1C3C-421F-95A0-BA8784B26207Q34451942-CF1B1C1F-3F4E-430B-A07A-5D37238CDBF6Q34603206-F8ACF8E4-D456-4E68-9BE9-B2172EE6DC36Q35125981-B9A57193-65EE-4C0B-B3B0-EFBEF95164AFQ35827465-DE14920F-71D5-498F-81CD-66A8F7644AF4Q35975302-D1EF24A2-2A1D-4537-9130-4B9B4072FB9FQ36349537-19273211-AC0B-41B3-B731-42832C3B4423Q36365138-410D790B-2B0D-4A28-BCB8-A5405CAB84BDQ36367835-65393461-EA7C-4331-97F0-09CB4055C9B7Q36548393-6126FF14-087E-402C-A9E2-9D07F9DB11B1Q37124059-0F1DBF05-7390-4834-A0C6-567D63EB0CF4Q37891258-E54DE787-1346-4454-A7C8-BEE86F931ACAQ38672601-32483051-120F-4D7C-AFA7-25D0B76884B5Q38786058-556A171A-D756-4236-BB27-DC6FD7E0956DQ40365091-0AD17CEF-3F3F-45C2-8BA6-5B1B579C3561Q40947861-3EA4CFBB-D8B1-4844-9609-153C9BE0926DQ41980071-AD99B137-940A-4010-A348-6AD54F5771D4Q42645331-7CA88A74-0DF3-4988-89F3-FD9F0E0C8E91Q45160487-FE3C362D-0486-477F-848B-10CACC606F3AQ46217457-92CB6F0B-3EE3-40EE-A458-8A9B22346327Q47845007-AD7672B5-55F3-4D0E-B209-E8838C86FD8CQ48138953-A2CE7C3C-BC5F-42D8-BB03-82216AEA11E4
P2860
Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Virus-encoded serine proteinas ...... ment after balloon angioplasty
@ast
Virus-encoded serine proteinas ...... ment after balloon angioplasty
@en
Virus-encoded serine proteinas ...... ment after balloon angioplasty
@nl
type
label
Virus-encoded serine proteinas ...... ment after balloon angioplasty
@ast
Virus-encoded serine proteinas ...... ment after balloon angioplasty
@en
Virus-encoded serine proteinas ...... ment after balloon angioplasty
@nl
prefLabel
Virus-encoded serine proteinas ...... ment after balloon angioplasty
@ast
Virus-encoded serine proteinas ...... ment after balloon angioplasty
@en
Virus-encoded serine proteinas ...... ment after balloon angioplasty
@nl
P2093
P1433
P1476
Virus-encoded serine proteinas ...... ment after balloon angioplasty
@en
P2093
G McFadden
M L Hobman
P304
P356
10.1161/01.CIR.94.11.2890
P407
P577
1996-12-01T00:00:00Z